Afamitresgene autoleucel 40000000 CELLS/ML
RxNorm 2690266

Concept Hierarchy & Relationship Mapping

RxNorm Concept Unique Identifier (RxCUI) 2690266 represents a standardized clinical drug concept used for cross-system interoperability. This concept aggregates multiple Atom IDs (AUIs), which are specific naming variations and synonyms used across pharmaceutical databases to ensure accurate medication mapping for: afamitresgene autoleucel 40000000 CELLS/ML.

The following semantic concepts and normalized strings are associated with this clinical entity:

SCDC
Afamitresgene autoleucel 40000000 CELLS/ML
AUI:12907111
View

This clinical crossover tool is designed for healthcare professionals, pharmacists, and data analysts to safely compare substitute products and manage medication interoperability.

SCDCPrescribable

Semantic Clinical Drug Component (SCDC):
Afamitresgene autoleucel 40000000 CELLS/ML
(Atom ID: 12907111)

Clinical Status & Identity

Prescribable Status
YES (Active)
Part of the RxNorm Current Prescribable Content subset including all drugs available for prescription in the USA.
Concept Description
afamitresgene autoleucel 40000000 CELLS/ML
Official description of the drug concept as defined in the source vocabulary.
Suppress Flag
N
N: Not suppressible | O: Obsolete | Y: Suppressed by editor | E: Unquantified non-prescribable drug.

Interoperability & Coding

Concept ID (RxCUI)
2690266
RxNorm Unique Identifier for the standardized concept.
Atom ID (RXAUI)
12907111
Unique identifier for this specific name variation (Atom).
Term Type (TTY)
SCDC
Semantic Clinical Drug Component (Ingredient + Strength)
Source Code
2690266
The "Most useful" identifier asserted by the original source vocabulary.

Source & Registry Data

Source Name
RxNorm Vocabulary (RXNORM)
The official name and abbreviation for the vocabulary source.
Source Version
20AA_260601F
The specific version of the vocabulary provided by the source.
Update Date
June 01, 2026
The date when this RxNorm data was last updated by the NLM.
License Contact
RxNorm Customer Service, , U.S. National Library of Medicine, 8600 Rockville Pike, , Bethesda, MD, United States, 20894, (888) FIND-NLM, , https://support.nlm.nih.gov/support/create-case/, https://www.nlm.nih.gov/research/umls/rxnorm/
Source licensing contact information.

Technical Attributes & Logic

RXN BOSS STRENGTH DENOM UNIT
ML
RXN Boss Strength Denom Unit
RXN BOSS STRENGTH DENOM VALUE
1
RXN Boss Strength Denom Value
RXN BOSS STRENGTH NUM UNIT
CELLS
RXN Boss Strength Num Unit
RXN BOSS STRENGTH NUM VALUE
40000000
RXN Boss Strength Num Value
RXN STRENGTH
40000000 CELLS/ML
Strength plus unit of SCDC

Patient Education

Afamitresgene Autoleucel Injection


Afamitresgene autoleucel is used in adults to treat certain types of synovial sarcoma that cannot be treated with surgery or is unresponsive to other treatments. Afamitresgene autoleucel is in a class of medications called autologous cellular immunotherapy, a type of medication prepared using cells from the patient's own blood. It works by causing the body's immune system (a group of cells, tissues, and organs that protects the body from attack by bacteria, viruses, cancer cells, and other substances that cause disease) to fight the cancer cells.
[Learn More]


* Please review the disclaimer below.